
Revolutionizing Cancer Care | Caris Life Sciences
Caris is a leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human …
Physicians | Caris Life Sciences
Caris helps improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in tissue or blood, plus …
Physician Tests - Caris Life Sciences
Caris’ industry-leading laboratories help improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in …
Order - Caris Life Sciences
Caris Life Sciences combines the use of sophisticated tumor profiling technologies with leading edge bioinformatics capabilities to advance precision medicine in ways that only we can.
About | Caris Life Sciences
With a primary focus on cancer, Caris has built a market-leading portfolio of precision medicine tools that have helped more than half a million cancer patients worldwide.
Investor Relations | Caris Life Sciences, Inc.
Jan 12, 2026 · Caris Life Sciences® was founded in 2008 with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize …
Patients | Caris Life Sciences
Caris Life Sciences provides patients with resources on molecular profiling, financial assistance, and personalized cancer treatment options to empower informed decisions.
Research - Caris Life Sciences
Explore how a convergence of rapid advances in next-generation sequencing, machine learning, artificial intelligence and computing power has driven Caris research, collaborations and inventions.
Contact | Caris Life Sciences
Reach out to Caris Life Sciences for customer support at 1.888.979.8669, billing inquiries at 1.877.630.6223, or visit our corporate headquarters in Irving, TX.
Caris Assure | Caris Life Sciences
Caris Assure® is a liquid biopsy that provides a minimally invasive blood test for comprehensive molecular analysis of tumor biomarkers, guiding personalized cancer therapy.